« Participation in Bill & Melinda Gates Foundation Grant | Main | Equity and Loan Financing »

Initiation of Phase I clinical trial

MinervaX announced today that the company has initiated a Phase I clinical trial for its GBS vaccine candidate GBS-NN. The Phase I trial will enrol up to 310 healthy adult women in two parts, Part A, which is a safety and dose-escalation trial in up to 70 women, and Part B, which is an extended safety and dose confirmation trial in up to 240 women.

Press release
Statement from Professor Paul Heath, UK
Statement from Group B Strep Association, US